Joel Greenblatt fit · Magic Formula - high ROIC + cheap EV/EBIT
Is Jazz Pharmaceuticals plc (JAZZ) a Joel Greenblatt Stock?
Partial match - either cheap or high-quality, but not both.
42/100
DNot a fit
1/5 criteria passed
+2 sector-quality lift. Top-quintile within its sector on 1 of 5 quality metrics. Raw pillar score 40 → lifted to 42 before grade derivation.
Joel Greenblatt's Criteria, Applied to JAZZ
EBIT/EV yield ≥ 10%
key1.2%
ROIC ≥ 25%
key-0.6%
EV/EBIT ≤ 12
82.8x
Gross margin ≥ 30%
84.1%
Earnings yield ≥ 6%
0.2%
How JAZZ Scores on Other Strategies
Live Financial Snapshot
Market cap
$14.6B
P/E (TTM)
501.8x
ROIC (TTM)
-0.62%
Gross margin
84.12%
Other Joel Greenblatt fit reports
Frequently Asked Questions
What is JAZZ's Joel Greenblatt fit score?
JAZZ scores 42/100 on our Joel Greenblatt fit engine - grade D. Partial match - either cheap or high-quality, but not both.
Does Joel Greenblatt actually own JAZZ?
Our score is computed from financial fundamentals against Joel Greenblatt's published criteria. We don't claim that Joel Greenblatt personally owns or recommends JAZZ.
How often is this score updated?
JAZZ's Joel Greenblatt fit score is recomputed daily from the latest TTM financials. The page below shows when it was last refreshed.
Key terms in this analysis
Educational tool, not investment advice. Scores are computed from publicly-available financial data against published investing-strategy criteria. We do not claim that Joel Greenblatt personally owns or recommends JAZZ.